文献速递慢性肾脏病遗传性与小管间质肾病

极低胎龄新生儿尿生物标志物与CKD的关联

Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age Neonates.
PubMed 文献 · Am J Kidney Dis · 2023-11-04

本研究基于PENUT和REPaIReD队列,纳入327例24-27周胎龄新生儿,评估尿生物标志物与2岁校正胎龄时eGFR<90mL/min/1.73m2的关联。调整胎龄周数后,α-GST、白蛋白和胱抑素C在发生CKD的新生儿中较高,但白蛋白和胱抑素C经Bonferroni-Holm校正后无显著差异;探索性病例对照分析未发现任何生物标志物差异。

要点

  • 调整胎龄后,发生CKD组尿α-GST对数差异0.27(95%CI 0.12-0.43)高于未发生组。
  • 尿白蛋白和胱抑素C在Bonferroni-Holm校正后未保持显著差异。
  • 探索性病例对照分析中,病例组与对照组间任何生物标志物均无差异。

核心结论

  • 尿生物标志物检测可能有助于监测有CKD风险的新生儿,但需进一步研究证实。

研究设计与样本

  • 队列研究,并对其中一部分进行探索性病例对照研究;纳入327例24-27周胎龄、有2年eGFR数据的新生儿,来自PENUT和REPaIReD研究。

主要发现

  • 调整胎龄周数后,发生CKD组尿α-谷胱甘肽-S-转移酶(α-GST)对数差异为0.27(95%CI 0.12-0.43),高于未发生CKD组。
  • 调整胎龄周数后,发生CKD组尿白蛋白对数差异为0.13(95%CI 0.02-0.25),高于未发生CKD组。
  • 调整胎龄周数后,发生CKD组尿胱抑素C对数差异为0.19(95%CI 0.04-0.34),高于未发生CKD组。
  • 尿白蛋白和胱抑素C在Bonferroni-Holm校正后未保持显著差异。
  • 探索性病例对照分析中,病例组与对照组间任何生物标志物均无差异。

关键数值与推荐

  • 主要队列在27、30和34周经后年龄测量11种尿生物标志物;探索性病例对照研究另测10种生物标志物。
  • 结局为2岁校正胎龄时eGFR<90mL/min/1.73m2。
  • 队列分析调整性别、胎龄和体重指数;病例对照研究按这些变量匹配。

临床怎么用

  • 测量尿生物标志物可能辅助监测有CKD风险的新生儿。

局限性

  • 早期死亡和2岁校正胎龄时无eGFR数据的受试者数量多。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Children born before 28 weeks' gestation are at increased risk of chronic kidney disease (CKD). Urine biomarkers may shed light on mechanistic pathways and improve the ability to forecast CKD. We evaluated whether urinary biomarkers in neonates of low gestational age (GA) are associated with a reduced estimated glomerular filtration rate (eGFR) over time. STUDY DESIGN: A cohort study of neonates with an exploratory case-control study of a subset of the cohort. SETTING & PARTICIPANTS: 327 neonates born at 24-27 weeks' gestation with 2-year eGFR data from the PENUT (Preterm Erythropoietin Neuroprotection Trial) and the REPaIReD (Recombinant Erythropoietin for Prevention of Infant Renal Disease) study. EXPOSURES: 11 urinary biomarkers measured at 27, 30, and 34 weeks' postmenstrual age for the primary cohort study and 10 additional biomarkers for the exploratory case-control study. OUTCOMES: eGFR<90mL/min/1.73m2 at 2 years corrected for GA. ANALYTICAL APPROACH: Linear mixed models to assess differences in biomarker values between neonates in whom CKD did and did not develop, accounting for multiple comparisons using Bonferroni-Holm correction in the cohort study only. Cohort analyses were adjusted for sex, GA, and body mass index. Cases were matched to controls on these variables in the case-control study. RESULTS: After adjusting for weeks of GA, urinary levels of α-glutathione-S-transferase (log difference, 0.27; 95% CI, 0.12-0.43), albumin (log difference, 0.13; 95% CI, 0.02-0.25), and cystatin C (log difference, 0.19; 95% CI, 0.04-0.34) were higher in those in whom CKD developed than in those in whom it did not. Urinary albumin and cystatin C levels did not remain significantly different after Bonferroni-Holm correction. In the exploratory case-control analysis, there were no differences in any biomarkers between cases and controls. LIMITATIONS: Early deaths and a high number of subjects without eGFR at 2 years corrected for GA. CONCLUSIONS: Measurement of urinary biomarkers may assist in monitoring neonates who are at risk for CKD. Additional studies are needed to confirm these findings. FUNDING: Grants from government (National Institutes of Health). TRIAL REGISTRATION: Registered at ClinicalTrials.gov with study number NCT01378273. PLAIN-LANGUAGE SUMMARY: Approximately 15 million neonates worldwide are born prematurely, and 2 million are born before 28 weeks' gestation. Many of these children go on to experience chronic kidney disease. Urine biomarkers may allow for early recognition of those at risk for the development of kidney disease. In this study of more than 300 children born before 28 weeks' gestational age, we found higher mean urinary levels of α-glutathione-S-transferase at 27, 30, and 34 weeks in children whose estimated glomerular filtration rate was<90mL/min/1.73m2 at 2 years compared with children whose estimated glomerular filtration rate was>90mL/min/1.73m2 at 2 years. Measurement of urinary biomarkers may assist in monitoring neonates who are at risk for chronic kidney disease. Additional studies are needed to confirm our findings.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Hingorani SR, Schmicker RH, Halloran B, et al. Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age Neonates. Am J Kidney Dis. 2023. PMID: 37926336. doi:10.1053/j.ajkd.2023.09.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。